Boston, MA -- (SBWIRE) -- 10/14/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Biozone Pharmaceuticals Inc(OTCBB:BZNE), The Gap Inc.(NYSE:GPS), MannKind Corporation(NASDAQ:MNKD), XenoPort, Inc.(NASDAQ:XNPT).
Biozone Pharmaceuticals Inc(OTCBB:BZNE) opened its shares at the price of $0.50 for the day. Its closing price was $0.510 after gaining +5.15% for the day. The company traded with the total volume of 1.79 million shares, while its average trading volume remained 1.17 million shares. The beta of BZNE stands at -22.37.
Biozone Pharmaceuticals, Inc., through its subsidiaries, engages in developing and manufacturing over the counter (OTC) drug products, and cosmetic and beauty products on behalf of third parties in the United States and internationally. Its OTC products include hair conditioners and shampoos for treatment of eczema and psoriasis; external analgesics; skin protectants
For How Long BZNE will Fight for Profitability? Read This Trend Analysis report
The Gap Inc.(NYSE:GPS) percentage change plunged -6.17% to close at $36.83 with the total traded volume of 17.69 million shares, and average volume of 3.72 million. The 52 week range of the stock remained $29.84 - $46.65, while its day lowest price was $36.45 and it hit its day highest price at $37.25.
The Gap, Inc. operates as an apparel retail company. It offers apparel, accessories, and personal care products for men, women, children, and babies under the Gap, Old Navy, Banana Republic, Piperlime, Athleta, and Intermix brands.
Has GPS Found The Bottom And Ready To Gain Momentum? Find Out Here
MannKind Corporation(NASDAQ:MNKD) started its trading session with the price of $5.16 and closed at $5.11 by losing -2.11%. MNKD stocks traded with total volume of 4.82 million shares, while the average trading volume remained 4.89 million shares. The beta of MNKD stands at1.63. Day range of the stock was $5.01 -$5.19.
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate includes AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia.
Why Should Investors Buy MNKD After the Recent Fall? Just Go Here and Find Out
XenoPort, Inc.(NASDAQ:XNPT) ended its day with the loss of -2.26% and closed at the price of $5.62 after opening at $5.72. Stock traded during its last trading session with the total volume of 2.91 million shares, as compared to its average volume of 526,017 shares.
XenoPort, Inc., a biopharmaceutical company, focuses on developing and commercializing a portfolio of internally discovered product candidates for the treatment of neurological disorders.
Will XNPT Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)